The world is experiencing an unprecedented vision health challenge. Myopia, commonly known as nearsightedness, has evolved from a simple refractive error requiring corrective lenses into a global epidemic affecting billions of people. With nearly 30% of the world’s population currently affected by myopia – and projections reaching 50% by 2050 understanding this condition has become critical not only for eye care professionals but also for the manufacturers producing the advanced lenses designed to address it.
This comprehensive guide explores what is myopia, examines its causes, symptoms, and treatment options, and reveals how cutting-edge measurement technology enables the production of sophisticated myopia-control lenses that are reshaping vision care worldwide.
What is Myopia? A Complete Definition
Myopia is a refractive error in which light entering the eye focuses in front of the retina rather than directly on it, causing distant objects to appear blurred while near objects remain clear. The condition typically develops when the eyeball grows too long from front to back, or when the cornea or lens has excessive curvature.
When someone asks “what is myopia?” the simplest answer is that it’s a mismatch between the eye’s optical power and its physical length. In a normally-sighted eye, incoming light rays converge precisely on the retina, creating a sharp image. In a myopic eye, these rays converge too soon, resulting in a blurred image of distant objects by the time light reaches the retina.
The severity of myopia is measured in diopters (D), with negative values indicating the degree of nearsightedness. Mild myopia ranges from -0.50D to -3.00D, moderate myopia from -3.00D to -6.00D, and high myopia exceeds -6.00D. Understanding what is the highest myopia reveals cases exceeding -20.00D, though such extreme cases are relatively rare.
Bilateral myopia – myopia of both eyes – is by far the most common presentation, though the degree of myopia may differ between eyes. When myopia affects both eyes to a similar degree, it’s referred to as symmetric bilateral myopia.
Myopia Symptoms: Recognizing the Signs
Identifying myopia symptoms early is crucial for effective intervention, particularly in children when the condition typically develops and progresses most rapidly. The primary myopia symptoms include:
Distance vision blur represents the hallmark symptom – difficulty seeing distant objects clearly while near vision remains unaffected. Children may squint to see the board at school, sit unusually close to televisions, or hold books very close to their faces.
Eye strain and headaches often accompany uncorrected myopia as the visual system struggles to compensate for the refractive error. Frequent rubbing of the eyes, complaints of tired eyes after visual tasks, and persistent headaches – particularly after extended periods of distance viewing – may indicate undiagnosed myopia.
Difficulty with night vision is common among myopic individuals, as pupil dilation in low light conditions can exacerbate the effects of the refractive error. Halos around lights and reduced contrast sensitivity compound nighttime visual challenges.
For parents and educators, behavioral signs often provide the first indication of childhood myopia: declining academic performance, reluctance to participate in sports requiring distance vision, and frequent blinking or eye rubbing warrant professional evaluation.
What Causes Myopia? Understanding the Origins
The question of “what causes myopia” has driven decades of research, revealing a complex interplay of genetic and environmental factors. Understanding myopia causes is essential for developing effective prevention and treatment strategies.
Genetic factors play a significant role in myopia development. Children with one myopic parent face approximately three times the risk of developing myopia, while those with two myopic parents face six times the risk. However, genetics alone cannot explain the dramatic increase in myopia prevalence over recent decades – a timeframe far too short for genetic changes to account for the shift.
Environmental factors have emerged as primary drivers of the myopia epidemic. Extended near work – reading, screen time, and close-focus activities – has been strongly associated with myopia development and progression. The mechanism involves sustained accommodation (focusing effort) that may trigger eye elongation over time.
Insufficient outdoor time represents perhaps the most modifiable risk factor. Research consistently demonstrates that children spending more time outdoors have significantly lower myopia rates, regardless of near work levels. The protective mechanism may involve light intensity, the optical properties of natural environments, or dopamine release stimulated by bright light exposure.
Educational intensity correlates strongly with myopia prevalence, helping explain the extremely high rates in East Asian populations where academic pressure and study time are particularly intense. However, myopia rates are rising globally across all educational systems.
When examining what causes myopia at the cellular level, researchers have identified peripheral hyperopic defocus as a key driver of eye elongation. When the peripheral retina receives images focused behind it (hyperopic defocus), biochemical signals trigger continued axial growth – worsening myopia. This discovery has revolutionized lens design for myopia management.
Myopia vs Hyperopia: Understanding the Difference
Understanding myopia vs hyperopia clarifies two opposite refractive conditions. While myopia causes distant objects to appear blurred, hyperopia (farsightedness) typically causes near objects to appear blurred, though young hyperopic individuals may compensate through accommodation.
The fundamental distinction in hyperopia vs myopia lies in where light focuses relative to the retina: myopia focuses light in front of the retina (eye too long or too powerful), while hyperopia focuses light behind the retina (eye too short or insufficient power).
| Characteristic | Myopia | Hyperopia |
| Light focus | In front of retina | Behind retina |
| Distance vision | Blurred | Usually clear |
| Near vision | Clear | May be blurred |
| Eye length | Too long | Too short |
| Corrective lens | Negative (minus) | Positive (plus) |
| Common onset | Childhood/adolescence | Often present from birth |
| Progression | Typically worsens until early adulthood | May decrease with eye growth |
The myopia vs hyperopia distinction has significant implications for lens design and manufacturing. Myopia-control lenses must incorporate specific optical features – peripheral myopic defocus – that would be inappropriate or counterproductive for hyperopic correction.
Myopia and Astigmatism: When Conditions Combine
Myopia and astigmatism frequently occur together, creating compound refractive errors that require more complex correction. Astigmatism involves unequal curvature of the cornea or lens, causing light to focus at multiple points rather than a single point. When combined with myopia, the visual result includes both distance blur and directional distortion.
The combination of myopia and astigmatism presents particular challenges for lens manufacturers. Toric designs must incorporate both spherical myopia correction and cylindrical astigmatism correction with precise axis alignment. For myopia-control lenses, adding astigmatism correction while maintaining therapeutic peripheral defocus zones requires sophisticated optical design and equally sophisticated verification technology.
Manufacturing lenses that address myopia and astigmatism simultaneously demands measurement systems capable of verifying:
- Spherical power accuracy for myopia correction
- Cylindrical power accuracy for astigmatism correction
- Axis alignment precision
- Peripheral defocus zone positioning and power
- Optical zone centration
This complexity explains why advanced measurement technology has become essential for modern lens production.
Severe Myopia and Degenerative Myopia: Understanding High-Risk Cases
While any degree of myopia increases certain eye health risks, severe myopia and high myopia (exceeding -6.00D) carry substantially elevated risks of sight-threatening complications. Degenerative myopia, also called pathological myopia, represents the most serious form, characterized by progressive retinal and choroidal changes that can lead to permanent vision loss.
Degenerative myopia involves structural changes beyond simple refractive error:
Posterior staphyloma – outpouching of the back of the eye occurs in many severe myopia cases, distorting the retina and impairing central vision. Myopic macular degeneration involves atrophy of the macula, the central retinal area responsible for detailed vision. Retinal detachment risk increases dramatically with axial length, as the stretched, thinned retina becomes more susceptible to tears and separation.
Lacquer cracks – breaks in Bruch’s membrane underlying the retina can lead to choroidal neovascularization (abnormal blood vessel growth) that threatens central vision. Glaucoma risk approximately doubles with high myopia, and cataracts develop earlier and more frequently in highly myopic individuals.
The serious consequences of severe myopia and degenerative myopia underscore the importance of slowing myopia progression during childhood when intervention can reduce ultimate myopia severity. Every diopter of myopia prevented represents meaningful reduction in lifetime complication risk.
This reality has driven intense development of myopia-control lenses and the measurement technology required to produce them reliably.
Myopia Treatment: From Basic Correction to Active Control
Myopia treatment has evolved dramatically from simple optical correction to active progression management. Understanding the full spectrum of myopia treatments reveals options ranging from conventional correction to sophisticated therapeutic approaches.
Conventional Correction
Traditional myopia treatment focuses on providing clear vision through optical correction without attempting to slow progression:
Single-vision spectacle lenses remain the most common correction method, using negative-powered lenses to shift the focal point back onto the retina. While effective for vision correction, standard single-vision lenses provide no myopia control benefit and may even accelerate progression due to peripheral hyperopic defocus.
Contact lenses offer cosmetic and practical advantages but, in standard single-vision designs, similarly lack myopia control properties. Soft lenses, rigid gas permeable (RGP) lenses, and daily disposable options all serve correction purposes without therapeutic benefit.
Refractive surgery (LASIK, PRK, SMILE) permanently reshapes the cornea to correct myopia in adults whose prescription has stabilized. However, surgery addresses the optical error without affecting the underlying axial elongation that causes high myopia complications.
Myopia Management: Therapeutic Approaches
Myopia management encompasses treatments designed to slow myopia progression rather than simply correct existing error:
Orthokeratology (Ortho-K) uses specially designed rigid lenses worn overnight to temporarily reshape the cornea, providing clear daytime vision without correction while creating peripheral myopic defocus that slows eye elongation. Studies demonstrate 40-60% reduction in myopia progression with orthokeratology.
Multifocal soft contact lenses designed for myopia control incorporate central distance correction with peripheral add power to create myopic defocus signals. The FDA-approved MiSight lens has demonstrated approximately 59% reduction in myopia progression over three years.
Atropine eye drops in low concentrations (0.01-0.05%) slow myopia progression through mechanisms not fully understood, possibly involving retinal signaling pathways. Combination therapy with optical interventions may provide additive benefit.
Myopia-control spectacle lenses represent the newest category of myopia treatments, offering therapeutic benefit in a convenient, non-invasive format:
- DIMS (Defocus Incorporated Multiple Segments) technology, pioneered by Hoya in the MiYOSMART lens, incorporates approximately 400 tiny lenslets creating +3.50D peripheral myopic defocus. Clinical studies demonstrate approximately 60% reduction in myopia progression.
- DOT (Defocus Incorporated Technology) from Essilor uses concentric rings of aspherical micro-lenses in the Stellest lens to create a volume of myopic defocus while maintaining clear central vision.
- HAL (Highly Aspherical Lenslets) designs incorporate sophisticated optical profiles that maximize therapeutic effect while minimizing visual disturbance.
The manufacturing of these advanced myopia treatments presents unprecedented measurement challenges that require specialized verification technology.
Myopia Control Lenses: The Manufacturing Challenge
Myopia control lenses represent some of the most optically complex spectacle lenses ever manufactured. Unlike conventional lenses with relatively uniform optical properties, myopia lens designs for progression control incorporate hundreds or even thousands of distinct optical zones working together to create therapeutic effects.
The complexity of myopia control lenses creates an unprecedented measurement challenge that has transformed quality control requirements for lens manufacturers.
Why Traditional Measurement Fails
Consider the measurement requirements for a DIMS-technology myopia lens:
Hundreds of optical zones – A single lens contains approximately 400 individual micro-lenslets, each requiring its own power verification. A conventional focimeter measures power at a single point, capturing perhaps 0.25% of the lens’s optical structure.
Sub-millimeter positioning – The therapeutic effect depends on precise positioning of defocus zones relative to the pupil. Zone positioning errors of less than 1mm can significantly impact effectiveness. Traditional point measurements provide no spatial information about zone location.
Complex power gradients – Peripheral defocus designs require verification of power distribution across the entire lens surface, not just at discrete measurement points.
Manufacturing consistency – Every myopia lens must match design specifications. Variations acceptable in conventional lenses may render myopia-control lenses therapeutically ineffective.
The Resolution Requirement
For meaningful verification of myopia control lenses, manufacturers need technology that can:
- Capture complete power distribution across the entire lens surface
- Resolve individual micro-lens elements with sub-millimeter spatial resolution
- Measure with sufficient accuracy to verify therapeutic power levels (typically ±0.03D)
- Complete measurements fast enough to enable 100% production inspection
Traditional lens measurement instruments, designed for simple single-vision or progressive lenses, are entirely inadequate for these requirements. A focimeter sampling 3-5 points cannot verify 400 micro-lenslets. Even sophisticated multi-point systems sampling 20-50 locations capture only a fraction of the optical structure.
This measurement gap has driven development of advanced full-surface mapping technology capable of characterizing the complex optical designs that define modern myopia control lenses.
Moiré Deflectometry: The Technology Enabling Myopia-Control Lens Production
The measurement requirements of myopia control lenses demand technology capable of capturing complete optical characterization in a single measurement. Moiré deflectometry, a wavefront-sensing technology pioneered by Rotlex, meets this challenge by mapping power distribution across the entire lens surface simultaneously.
How Moiré Deflectometry Works
The Moiré effect occurs when two repetitive patterns (gratings) overlay at slight angles, creating visible fringe patterns extremely sensitive to optical variations. In lens measurement:
Wavefront capture – When collimated light passes through a lens, the wavefront becomes curved according to local optical power. Higher power regions bend light more strongly.
Grating interaction – The distorted wavefront passes through precision Ronchi gratings. The wavefront slope at each point determines fringe pattern characteristics.
Single-shot acquisition – A high-resolution camera captures the complete fringe pattern in a single 20-50 millisecond exposure, with no moving parts required.
Algorithmic reconstruction – Fourier transform algorithms extract wavefront slope at every pixel location, then mathematical integration converts slope data to optical power, producing a complete power map.
Why Moiré Deflectometry Excels for Myopia-Control Lenses
Full-surface measurement – Every point across the lens surface is measured simultaneously, capturing all micro-lenses, zones, and gradients in a single acquisition.
High spatial resolution – Modern implementations achieve spatial resolution better than 0.1mm, sufficient to resolve individual micro-lenslets in DIMS designs (typically 1.03mm diameter).
Sub-diopter accuracy – Power measurement accuracy of ±0.02D to ±0.03D ensures reliable verification of therapeutic power levels.
Motion-free operation – With no moving parts, systems maintain calibration stability over months or years without mechanical drift – critical for production environments requiring consistent accuracy across thousands of measurements daily.
Production-compatible speed – Complete measurement in 4-16 seconds enables 100% inspection at manufacturing line rates.
Rotlex Solutions for Myopia-Control Lens Verification
Rotlex has pioneered the application of Moiré deflectometry in ophthalmic lens measurement, developing systems specifically optimized for the challenges of myopia control lenses and other advanced optical designs.
SMC+ (Surface Mapping Complete)
The SMC+ represents the state of the art for myopia lens verification, designed specifically for the ultra-high resolution requirements of DIMS, DOT, and other micro-lens array designs.
| Specification | SMC+ Performance |
| Measurement points | >500,000 per lens |
| Spatial resolution | <0.1mm |
| Power accuracy | ±0.03D |
| Power range | -20D to +20D |
| Cylinder range | 0 to 10D |
| Measurement time | 16 seconds |
| Lens diameter | Up to 80mm |
Dedicated analysis algorithms detect and characterize micro-lens arrays, verify zone positioning relative to optical center, calculate statistical distributions of lenslet powers, and compare measured power maps against design specifications.
Automated pass/fail determination ensures consistent quality decisions with detailed reporting for process feedback and continuous improvement.
FFV (Free-Form Verifier)
The FFV provides rapid verification of progressive and free-form lenses, completing measurements in just 4 seconds with ±0.02D accuracy. For manufacturers producing both conventional progressive lenses and myopia control lenses, the FFV handles high-volume progressive verification while the SMC+ addresses specialized myopia-control requirements.
Design file comparison enables automatic verification against SLF, DXF, and other design formats, identifying deviations between intended and manufactured optical performance.
Mapper
The Mapper provides detailed power mapping for single-vision, bifocal, aspheric, and progressive lenses with production-oriented speed. Operating in 4 seconds with 0.03D accuracy and 0.02D repeatability, the Mapper serves both end-of-line quality control and early-stage design evaluation.
Comprehensive capabilities include power, cylinder, axis, and addition measurement across the full lens surface, with built-in comparison functions for batch-to-batch consistency verification.
Contest 2 and Contest MP
For contact lens manufacturers producing myopia-control designs including orthokeratology and multifocal lenses, Contest 2 provides complete optical characterization in 3 seconds with 0.03D accuracy.
Full lens-type coverage includes soft, rigid, toric, multifocal, and Ortho-K designs, with radial profile analysis essential for verifying the complex power gradients required for myopia management effectiveness.
MCT-3000
The MCT-3000 provides ±1 µm thickness measurement accuracy for contact lenses and IOLs, essential for verifying the precise geometries that determine myopia-control lens performance.
The Motion-Free Advantage in Production
All Rotlex systems share a motion-free architecture that provides critical advantages for production measurement environments:
Calibration stability – With no moving parts to drift, wear, or require adjustment, systems maintain calibration accuracy over extended periods. Annual verification typically confirms continued accuracy rather than requiring recalibration.
Reduced maintenance – Eliminating motors, actuators, bearings, and encoders dramatically improves reliability and reduces operating costs.
Environmental robustness – Motion-free systems are inherently less sensitive to vibration, temperature changes, and other environmental factors affecting measurement accuracy.
Consistent accuracy – Every measurement occurs under identical conditions, eliminating measurement-to-measurement variation from mechanical positioning inconsistency.
For manufacturers inspecting thousands of myopia control lenses daily, these practical benefits translate directly to higher uptime, lower operating costs, and more reliable quality data.
Quality System Integration
Modern lens manufacturing demands seamless integration between measurement systems and quality management infrastructure. Rotlex systems provide comprehensive data management capabilities:
Automated data capture eliminates manual transcription, with every measurement automatically recorded including timestamp, system identification, and complete power map data.
Database connectivity enables direct connection to SQL databases, LIMS (Laboratory Information Management Systems), MES (Manufacturing Execution Systems), and ERP systems.
Statistical process control monitors measurement trends, alerting operators to process drift before out-of-specification product is produced.
Compliance support includes secure user authentication, electronic signatures, and tamper-evident audit trails supporting FDA 21 CFR Part 11 and ISO 13485 quality system requirements.
The Business Case: ROI of Advanced Measurement Technology
Investment in appropriate measurement technology for myopia control lenses delivers returns across multiple dimensions:
Defect detection – Complete power mapping identifies manufacturing issues invisible to point-measurement methods, preventing defective lenses from reaching customers.
Process optimization – Full-surface data enables identification of systematic manufacturing variations, supporting process improvements that reduce defect rates.
Throughput efficiency – Measurement times of 4-16 seconds enable 100% inspection without bottlenecking production.
Customer confidence – Comprehensive quality documentation demonstrates due diligence in verifying therapeutic lens performance.
Regulatory compliance – Automated data management supports quality system requirements while reducing documentation burden.
For manufacturers entering the rapidly growing myopia control lenses market, appropriate measurement capability is not optional – it’s essential for producing lenses that reliably deliver the therapeutic effect patients and practitioners expect.
The Myopia-Control Lens Market: Growth and Opportunity
The market for myopia control lenses is experiencing exceptional growth driven by the global myopia epidemic:
| Market Segment | 2024/2025 Value | Projected Value | CAGR |
| Myopia Control Lenses (all types) | $1.54 billion | $6.86 billion (2034) | 16.2% |
| Orthokeratology Lenses | $1.14 billion | $6.35 billion (2034) | 21.7% |
| Myopia Control Spectacle Lenses | $1.9 billion | $4.69 billion (2032) | 13.7% |
This growth reflects both increasing myopia prevalence and expanding adoption of myopia management strategies by eye care practitioners worldwide. Asia-Pacific leads current adoption, but North American and European markets are accelerating rapidly.
For lens manufacturers, this growth represents significant opportunity – but capturing market share requires production capability that ensures every lens meets the precise specifications necessary for therapeutic effectiveness.
Frequently Asked Questions
What is myopia and how is it different from other vision problems?
Myopia is a refractive error where light focuses in front of the retina, causing blurred distance vision while near vision remains clear. Unlike hyperopia (farsightedness) where light focuses behind the retina, or astigmatism where unequal curvature causes directional blur, myopia specifically affects distance vision. The condition typically develops during childhood and may progress until early adulthood.
What is the highest myopia recorded?
Extreme myopia cases exceeding -30.00D have been documented, though such severe cases are rare. High myopia is typically defined as exceeding -6.00D, affecting approximately 10% of myopic individuals. Degenerative myopia involves progressive structural changes beyond simple refractive error and carries significant risk of sight-threatening complications regardless of the exact diopter measurement.
Can myopia be cured?
Current myopia treatments correct the optical error but cannot reverse the underlying axial elongation. Refractive surgery (LASIK, PRK) permanently corrects the refractive error in adults but doesn’t address the structural changes that cause high myopia complications. Myopia management strategies aim to slow progression during childhood, reducing ultimate myopia severity and associated risks.
How do myopia-control lenses differ from regular glasses?
Conventional single-vision lenses correct central vision without affecting myopia progression – and may even accelerate it due to peripheral hyperopic defocus. Myopia control lenses incorporate specialized optical designs (micro-lens arrays, peripheral add power) that create myopic defocus signals slowing eye elongation. Manufacturing these lenses requires sophisticated optical designs and equally sophisticated measurement technology to verify therapeutic parameters.
Why can’t standard equipment measure myopia-control lenses?
Traditional focimeters measure power at single points – adequate for uniform lenses but fundamentally inadequate for designs containing hundreds of micro-lenslets. A DIMS lens with 400 micro-lenses requires measurement technology capturing the complete power distribution across the entire surface. Moiré deflectometry systems like the Rotlex SMC+ provide >500,000 measurement points per lens, enabling complete characterization of complex myopia-control designs.
What accuracy is required for myopia-control lens verification?
Therapeutic effectiveness depends on precise optical parameters. Power accuracy of ±0.03D or better ensures reliable verification of both central prescription zones and peripheral defocus elements. Spatial resolution below 0.1mm is necessary to resolve individual micro-lenslets in DIMS designs. Zone positioning accuracy within 0.5mm ensures therapeutic zones align correctly with the visual axis.
How does myopia and astigmatism affect lens design?
When myopia and astigmatism combine, lenses must incorporate both spherical myopia correction and cylindrical astigmatism correction with precise axis alignment. Adding myopia-control features to toric designs increases complexity significantly, requiring measurement systems capable of verifying all parameters simultaneously.
Conclusion: Meeting the Myopia Challenge
The global myopia epidemic presents both a public health challenge and a manufacturing opportunity. With prevalence projected to reach 50% of the world’s population by 2050, the demand for effective myopia treatments – particularly myopia control lenses – will continue growing for decades.
Understanding what is myopia, recognizing myopia symptoms, and addressing myopia causes through effective myopia management requires sophisticated optical solutions. The advanced lens designs emerging to meet this challenge DIMS, DOT, orthokeratology, multifocal contact lenses – represent remarkable optical engineering achievements.
However, designing effective lenses is only half the challenge. Manufacturing them consistently, verifying that every lens meets therapeutic specifications, and documenting quality for regulatory compliance demands measurement technology matching the sophistication of the designs themselves.
Moiré deflectometry provides the full-surface, high-resolution, production-compatible measurement capability that modern myopia control lenses require. Motion-free operation ensures the calibration stability and reliability that production environments demand.
For manufacturers committed to the myopia-control market, investment in appropriate measurement technology is not merely a quality consideration – it’s a strategic requirement for producing lenses that reliably deliver the therapeutic benefits patients need and practitioners expect.
Disclaimer: This document is intended for educational and operational guidance. It does not replace official Rotlex documentation or training. For specific regulatory requirements, consult with your quality assurance team and relevant regulatory authorities.
